Roche Vitamins, Inc. v. United States
2010 Ct. Intl. Trade LEXIS 147
Ct. Intl. Trade2010Background
- BetaTab 20% is a beta-carotene beadlet used as a dietary supplement ingredient with provitamin A activity; it is not a cold-water-soluble pigment and is marketed for antioxidant content rather than as a food colorant; it was imported in December 2002 and classified by Customs under HTSUS 2106.90.97 with an 8.5% ad valorem rate plus a per-kilogram duty; Roche protested Customs’ classification and filed suit in 2004; Roche sought classification under HTSUS 3204.19.35 (coloring matter) or 2936 (prov vitamins) or 3204 headings for duty-free PA treatment; prior stipulations addressed B-Carotene 7% CWS as classifiable under 3204.19.35; this case centers on whether BetaTab 20% falls under 3204 as a coloring matter or under other headings.
- The court applies HTSUS General Rules of Interpretation and Additional Rules of Interpretation to determine the proper classification de novo, considering whether 'coloring matter' is a principal-use provision and whether BetaTab 20% belongs to a class/kind principally used as coloring matter.
- The court notes precedent that E.M. Chems. v. United States treats 'coloring matter' as a principal-use provision and that ARI 1(a) governs principal-use analysis, requiring examination of factors like physical characteristics, intended use, channels of trade, and consumer expectations.
- The court concludes genuine issues of material fact remain about BetaTab 20%’s principal-use classification, particularly whether its beadlet formulation renders it 'primarily used as coloring matter' or as an ingredient for dietary supplements, precluding summary judgment on Heading 3204.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether BetaTab 20% falls under 3204.19.35 as coloring matter | Roche asserts BetaTab 20% is principally a colorant. | U.S. contends BetaTab 20% aligns with dietary supplement ingredients. | Not granted; issues remain material. |
| Whether ARI 1(a) principal-use framework applies to BetaTab 20% | Roche argues ARI 1(a) does not apply due to 'special language/context' for 3204.19.35. | Defendant asserts ARI 1(a) applies to determine the class/kind. | Applicable; genuine issues preclude summary judgment. |
| Whether BetaTab 20% is classifiable under 2936 (provitamins) | BetaTab 20% should be 2936 due to provitamin A content and stabilizers. | 2936 requires beta-carotene products to fit provitamin use with stabilizers not altering basic character. | Not appropriate for summary judgment; genuine issues remain. |
| PA eligibility under the Pharmaceutical Appendix | If under 3204.19.35, BetaTab 20% may be PA-eligible. | PA eligibility depends on proper Heading 3204 classification and use; unresolved at stage. | Not resolved at this stage. |
Key Cases Cited
- E.M. Chems. v. United States, 923 F. Supp. 202 (Ct. Int'l Trade 1996) (coloring-matter as a principal-use provision; ARI 1(a) applied)
- BASF Corp. v. United States, 391 F. Supp. 2d 1246 (Ct. Int'l Trade 2005) (Lucarotin 1% Beta-carotene classification under 3204 emphasized colorant use; affirmed by Fed. Cir.)
- BASF Corp. v. United States, 482 F.3d 1324 (Fed. Cir. 2007) (Fed. Cir. on BASF I/II; discussed duty-free eligibility for colorant-vs-vitamin uses)
- Lucarotin 1% (BASF I), 29 Cit. 681 (Ct. Int'l Trade 2005) (classification under 3204 in BASF I (addressed colorant use))
- Carborundum Co., 536 F.2d 373 (2d Cir. 1976) (factors for principal-use analysis in classification)
- Skidmore v. Swift & Co., 323 U.S. 134 (Supreme Court 1944) (weight given to agency interpretations in classification)